Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Long-term use of lenalidomide, especially following high-dose melphalan and autologous stem cell rescue, has been associated with an increased incidence of second solid tumours and haematopoietic malignancies, primarily MDS and AML.
“Long-term use of lenalidomide, especially following high-dose melphalan and autologous stem cell rescue, has been associated with an increased incidence of second solid tumours and haematopoietic malignancies, primarily MDS and AML34,126.”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [126]
Cites
Kumar, S., Dispenzieri, A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Gastineau, D. A., Litzow, M. R., Fonseca, R., Roy, V, Rajkumar, S. V., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404801 · Cited by 351 · see citing works
Singer, J. W., Longin, K., Appelbaum, F. R., et al. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb06744.x · Cited by 293 · see citing works
Prince, H. M., Imrie, K., Sutherland, D. R., et al. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.448987.x · Cited by 71 · see citing works
The effect of induction therapy with novel agents on stem cell mobilization in multiple myeloma
Mazumder, A., Jagannath, S., & Vesole, D. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.8102 · Cited by 6 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management
Rajkumar, S. V. (2011) · American Journal of Hematology · doi:10.1002/ajh.21913 · Cited by 152 · see citing works
Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
Jan, M., Sperling, A. S., & Ebert, B. L. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00479-z · Cited by 137 · see citing works
The application and biology of immunomodulatory drugs (IMiDs) in cancer
Pan, B., & Lentzsch, S. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.004 · Cited by 76 · see citing works
Micallef, I. N. M., Ho, A. D., Klein, L. M., Marulkar, S., Gandhi, P. J., & McSweeney, P. A. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.118 · Cited by 61 · see citing works
- Authors
- Mazumder, A., Kaufman, J., Niesvizky, R., Lonial, S., Vesole, D., & Jagannath, S.
- Affiliations
- Saint Vincent's Catholic Medical Center (US)
- Emory University (US)
- Cornell University (US)
- Corresponding author
- Mazumder, A
- Venue
- Leukemia
- Published
- 2007-11-22
- Volume
- 22
- Issue
- 6
- Pages
- 1280-1281
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2020445243
- Cited by
- 126
- References
- 4
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 8 · 2018: 3 · 2017: 9 · 2016: 6 · 2015: 6 · 2014: 3 · 2013: 6 · 2012: 15
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Leukemia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Keywords
- lenalidomide, multiple myeloma, autologous stem cell transplantation, peripheral blood stem cell mobilization, induction therapy, treatment-naive patients, hematopoietic recovery
- MeSH terms
- Lenalidomide, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy, Cyclophosphamide, Humans, Middle Aged, Multiple Myeloma, Thalidomide, Granulocyte Colony-Stimulating Factor, Treatment Outcome, Hematopoietic Stem Cell Mobilization, Peripheral Blood Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
